Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus.

Bauer JW, Baechler EC, Petri M, Batliwalla FM, Crawford D, Ortmann WA, Espe KJ, Li W, Patel DD, Gregersen PK, Behrens TW.

PLoS Med. 2006 Dec;3(12):e491.

2.

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.

Bauer JW, Petri M, Batliwalla FM, Koeuth T, Wilson J, Slattery C, Panoskaltsis-Mortari A, Gregersen PK, Behrens TW, Baechler EC.

Arthritis Rheum. 2009 Oct;60(10):3098-107. doi: 10.1002/art.24803.

3.
4.
5.

Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.

Cai Z, Wong CK, Kam NW, Dong J, Jiao D, Chu M, Lam CW, Tam LS.

Lupus. 2015 Oct;24(12):1257-66. doi: 10.1177/0961203315585815.

PMID:
25966926
6.

Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.

Steiman AJ, Gladman DD, Ibañez D, Noamani B, Landolt-Marticorena C, Urowitz MB, Wither JE.

J Rheumatol. 2015 Dec;42(12):2318-26. doi: 10.3899/jrheum.150040.

PMID:
26568589
7.

Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.

Li Y, Lee PY, Kellner ES, Paulus M, Switanek J, Xu Y, Zhuang H, Sobel ES, Segal MS, Satoh M, Reeves WH.

Arthritis Res Ther. 2010;12(3):R90. doi: 10.1186/ar3017.

8.

Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.

Morimoto AM, Flesher DT, Yang J, Wolslegel K, Wang X, Brady A, Abbas AR, Quarmby V, Wakshull E, Richardson B, Townsend MJ, Behrens TW.

Arthritis Rheum. 2011 Aug;63(8):2407-15. doi: 10.1002/art.30399.

9.

Pregnancy-associated inflammatory markers are elevated in pregnant women with systemic lupus erythematosus.

Björkander S, Bremme K, Persson JO, van Vollenhoven RF, Sverremark-Ekström E, Holmlund U.

Cytokine. 2012 Aug;59(2):392-9. doi: 10.1016/j.cyto.2012.04.046.

PMID:
22633082
10.

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.

Rose T, Grützkau A, Hirseland H, Huscher D, Dähnrich C, Dzionek A, Ozimkowski T, Schlumberger W, Enghard P, Radbruch A, Riemekasten G, Burmester GR, Hiepe F, Biesen R.

Ann Rheum Dis. 2013 Oct;72(10):1639-45. doi: 10.1136/annrheumdis-2012-201586.

PMID:
23117242
11.
12.

Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.

Somers EC, Zhao W, Lewis EE, Wang L, Wing JJ, Sundaram B, Kazerooni EA, McCune WJ, Kaplan MJ.

PLoS One. 2012;7(5):e37000. doi: 10.1371/journal.pone.0037000.

13.

A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.

Kim JM, Park SH, Kim HY, Kwok SK.

Int J Mol Sci. 2015 Jun 23;16(6):14158-70. doi: 10.3390/ijms160614158. Review.

14.

Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.

Willis R, Seif AM, McGwin G Jr, Martinez-Martinez LA, González EB, Dang N, Papalardo E, Liu J, Vilá LM, Reveille JD, Alarcón GS, Pierangeli SS.

Lupus. 2012 Jul;21(8):830-5. doi: 10.1177/0961203312437270.

16.

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.

Lood C, Amisten S, Gullstrand B, Jönsen A, Allhorn M, Truedsson L, Sturfelt G, Erlinge D, Bengtsson AA.

Blood. 2010 Sep 16;116(11):1951-7. doi: 10.1182/blood-2010-03-274605.

17.

Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.

Narumi S, Takeuchi T, Kobayashi Y, Konishi K.

Cytokine. 2000 Oct;12(10):1561-5.

PMID:
11023674
18.

Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.

Feng X, Reder NP, Yanamandala M, Hill A, Franek BS, Niewold TB, Reder AT, Javed A.

J Neurol Sci. 2012 Feb 15;313(1-2):48-53. doi: 10.1016/j.jns.2011.09.032.

19.

Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.

Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, Ellingson S, Newman B, Bauer JW, Peterson EJ, Baechler EC, Reed AM.

Arthritis Rheum. 2009 Nov;60(11):3436-46. doi: 10.1002/art.24936.

20.

[Serum level of selected chemokines in systemic lupus erythematosus patients taking into consideration the peripheral blood leukocyte counts].

Kopczyńska M, Franek A, Błaszczak E, Dworak J, Kopczyński P, Hrycek A.

Pol Merkur Lekarski. 2013 May;34(203):251-4. Polish.

PMID:
23894774

Supplemental Content

Support Center